474 related articles for article (PubMed ID: 33508027)
1. Kaposi's sarcoma-associated herpesvirus processivity factor (PF-8) recruits cellular E3 ubiquitin ligase CHFR to promote PARP1 degradation and lytic replication.
Chung WC; Lee S; Kim Y; Seo JB; Song MJ
PLoS Pathog; 2021 Jan; 17(1):e1009261. PubMed ID: 33508027
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Poly(ADP-Ribose) Polymerase 1 by a Viral Processivity Factor Facilitates Lytic Replication of Gammaherpesvirus.
Chung WC; Park JH; Kang HR; Song MJ
J Virol; 2015 Sep; 89(18):9676-82. PubMed ID: 26157130
[TBL] [Abstract][Full Text] [Related]
3. KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.
Combs LR; Spires LM; Alonso JD; Papp B; Toth Z
J Virol; 2022 Jun; 96(12):e0010122. PubMed ID: 35604218
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation.
Izumiya Y; Kobayashi K; Kim KY; Pochampalli M; Izumiya C; Shevchenko B; Wang DH; Huerta SB; Martinez A; Campbell M; Kung HJ
PLoS Pathog; 2013; 9(8):e1003506. PubMed ID: 23990779
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication.
Yang Z; Yan Z; Wood C
J Virol; 2008 Apr; 82(7):3590-603. PubMed ID: 18216089
[TBL] [Abstract][Full Text] [Related]
6. Suppressive regulation of KSHV RTA with O-GlcNAcylation.
Ko YC; Tsai WH; Wang PW; Wu IL; Lin SY; Chen YL; Chen JY; Lin SF
J Biomed Sci; 2012 Feb; 19(1):12. PubMed ID: 22300411
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus Viral Processivity Factor EA-D Facilitates Virus Lytic Replication by Inducing Poly(ADP-Ribose) Polymerase 1 Degradation.
Lee S; Kim J; Chung WC; Han JH; Song MJ
J Virol; 2022 Nov; 96(21):e0037122. PubMed ID: 36286483
[TBL] [Abstract][Full Text] [Related]
8. The Itch ubiquitin ligase is required for KSHV RTA induced vFLIP degradation.
Chmura JC; Herold K; Ruffin A; Atuobi T; Fabiyi Y; Mitchell AE; Choi YB; Ehrlich ES
Virology; 2017 Jan; 501():119-126. PubMed ID: 27912080
[TBL] [Abstract][Full Text] [Related]
9. Protein Degradation by Gammaherpesvirus RTAs: More Than Just Viral Transactivators.
Combs LR; Combs J; McKenna R; Toth Z
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992439
[TBL] [Abstract][Full Text] [Related]
10. KSHV RTA utilizes the host E3 ubiquitin ligase complex RNF20/40 to drive lytic reactivation.
Spires LM; Wind E; Papp B; Toth Z
J Virol; 2023 Nov; 97(11):e0138923. PubMed ID: 37888983
[TBL] [Abstract][Full Text] [Related]
11. Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF).
Ahmad H; Gubbels R; Ehlers E; Meyer F; Waterbury T; Lin R; Zhang L
J Biol Chem; 2011 Mar; 286(10):7865-7872. PubMed ID: 21212282
[TBL] [Abstract][Full Text] [Related]
12. Major Histocompatibility Complex Class II HLA-DRĪ± Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8.
Sun Z; Jha HC; Pei YG; Robertson ES
J Virol; 2016 Sep; 90(18):8047-58. PubMed ID: 27356905
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
14. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
Zhang L; Li DQ
Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
[TBL] [Abstract][Full Text] [Related]
15. NCOA2 promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus by enhancing the expression of the master switch protein RTA.
Wei X; Bai L; Dong L; Liu H; Xing P; Zhou Z; Wu S; Lan K
PLoS Pathog; 2019 Nov; 15(11):e1008160. PubMed ID: 31751430
[TBL] [Abstract][Full Text] [Related]
16. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
Wakeman BS; Izumiya Y; Speck SH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway.
Gould F; Harrison SM; Hewitt EW; Whitehouse A
J Virol; 2009 Jul; 83(13):6727-38. PubMed ID: 19369342
[TBL] [Abstract][Full Text] [Related]
19. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
Wang SE; Wu FY; Yu Y; Hayward GS
J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
Yang Z; Wood C
J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
